These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38274817)

  • 1. Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice.
    Liu L; van Schaik TA; Chen KS; Rossignoli F; Borges P; Vrbanac V; Wakimoto H; Shah K
    Front Immunol; 2023; 14():1324618. PubMed ID: 38274817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice.
    Liu L; van Schaik TA; Chen KS; Rossignoli F; Borges P; Vrbanac V; Wakimoto H; Shah K
    Front Immunol; 2024; 15():1466387. PubMed ID: 39161772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies.
    Khalsa JK; Shah K
    Cells; 2021 Feb; 10(3):. PubMed ID: 33668856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 7. Translational Orthotopic Models of Glioblastoma Multiforme.
    El Meskini R; Atkinson D; Weaver Ohler Z
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36876943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
    Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
    Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Microenvironment in Glioblastoma Subtypes.
    Chen Z; Hambardzumyan D
    Front Immunol; 2018; 9():1004. PubMed ID: 29867979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
    Seyfrid M; Maich WT; Shaikh VM; Tatari N; Upreti D; Piyasena D; Subapanditha M; Savage N; McKenna D; Mikolajewicz N; Han H; Chokshi C; Kuhlmann L; Khoo A; Salim SK; Archibong-Bassey B; Gwynne W; Brown K; Murtaza N; Bakhshinyan D; Vora P; Venugopal C; Moffat J; Kislinger T; Singh S
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.
    Khalsa JK; Cheng N; Keegan J; Chaudry A; Driver J; Bi WL; Lederer J; Shah K
    Nat Commun; 2020 Aug; 11(1):3912. PubMed ID: 32764562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
    Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
    Jahan N; Lee JM; Shah K; Wakimoto H
    Int J Cancer; 2017 Oct; 141(8):1671-1681. PubMed ID: 28567859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
    Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S
    Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid Cells in Glioblastoma Microenvironment.
    De Leo A; Ugolini A; Veglia F
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.
    Candolfi M; Curtin JF; Nichols WS; Muhammad AG; King GD; Pluhar GE; McNiel EA; Ohlfest JR; Freese AB; Moore PF; Lerner J; Lowenstein PR; Castro MG
    J Neurooncol; 2007 Nov; 85(2):133-48. PubMed ID: 17874037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy.
    Chen C; Jing W; Chen Y; Wang G; Abdalla M; Gao L; Han M; Shi C; Li A; Sun P; Jiang X; Yang Z; Zhang S; Zhang J; Tang C; Liu Y; Zhang R; Xu F; Dong B; Li X; Liu M; Qiang B; Sun Y; Wei X; Li J; Hu Q; Jiang X
    Sci Transl Med; 2022 Aug; 14(656):eabn1128. PubMed ID: 35921473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.
    Chen Z; Herting CJ; Ross JL; Gabanic B; Puigdelloses Vallcorba M; Szulzewsky F; Wojciechowicz ML; Cimino PJ; Ezhilarasan R; Sulman EP; Ying M; Ma'ayan A; Read RD; Hambardzumyan D
    Glia; 2020 Oct; 68(10):2148-2166. PubMed ID: 32639068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.